Non-alcoholic fatty liver disease, or NAFLD, affects almost a quarter of the global adult population (IMAGE)
Caption
A new CMJ article explores the possibility of using the transport protein Retinol-binding protein-4 as a therapeutic target to treat NAFLD
Credit
Albaraa Mehdar
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC